Frontal lobe hypometabolism and depression in Alzheimer's disease

Depression is common in Alzheimer's disease (AD). Clinicoanatomic studies in focal brain injuries and functional imaging studies both in primary depression and in depression secondary to neurologic diseases have demonstrated involvement of the frontal lobe. Frontal involvement has not been established in the depression of AD. We studied the correlation between focal brain metabolic abnormalities and depression in AD. In 53 patients with probable AD of minimal to moderate disability, we assessed the severity of depression using the Neuropsychiatric Inventory and correlated the depression score with regional cerebral glucose metabolism determined by 18F-fluorodeoxyglucose and PET. Depression was present in 19 patients (36%). The depression score correlated significantly with normalized glucose metabolic rates in the bilateral superior frontal and left anterior cingulate cortices. These results indicated an association between depression and decreased activity in the frontal lobe in AD and support frontal involvement, especially in the left side, in depression, irrespective of disease etiology.

[1]  J. Cummings,et al.  The neuroanatomy of depression. , 1993, The Journal of clinical psychiatry.

[2]  R. Post,et al.  Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[3]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[4]  R. Robinson,et al.  Mood disorders in stroke patients. Importance of location of lesion. , 1984, Brain : a journal of neurology.

[5]  Jeffrey L. Cummings,et al.  The spectrum of behavioral changes in Alzheimer's disease , 1996, Neurology.

[6]  S. Pappatà,et al.  Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.

[7]  H. Mayberg,et al.  Frontal lobe dysfunction in secondary depression. , 1994, The Journal of neuropsychiatry and clinical neurosciences.

[8]  S. Rapoport,et al.  Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. , 1991, Cerebrovascular and brain metabolism reviews.

[9]  B L Miller,et al.  Cerebral blood flow correlates of apathy in Alzheimer disease. , 1996, Archives of neurology.

[10]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[11]  H. Mayberg,et al.  Clinical correlates of PET- and SPECT-identified defects in dementia. , 1994, The Journal of clinical psychiatry.

[12]  R. Robinson,et al.  Mood change following left hemispheric brain injury , 1981, Annals of neurology.

[13]  J. Haxby,et al.  Positron emission tomography in Alzheimer's disease , 1986, Neurology.

[14]  E. Mori,et al.  [Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients]. , 1997, No to shinkei = Brain and nerve.

[15]  J. Cummings,et al.  Noncognitive neuropsychiatric syndromes in alzheimer’s disease , 1990 .

[16]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[17]  Karl J. Friston,et al.  The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression , 1992, Psychological Medicine.

[18]  T A Ketter,et al.  SPECT and PET imaging in mood disorders. , 1993, The Journal of clinical psychiatry.

[19]  Robert P. Friedland,et al.  Dementia: A Clinical Approach (2nd Ed.) , 1992 .

[20]  Iwao Kanno,et al.  Design and evaluation of HEADTOME-IV, a whole-body positron emission tomograph , 1989 .

[21]  K. Ishii,et al.  Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[23]  J. Cummings,et al.  The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[24]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[25]  J. Cummings,et al.  Depressive Symptoms in Alzheimer Disease: Assessment and Determinants , 1995, Alzheimer disease and associated disorders.

[26]  D. Jeste,et al.  Overview of depression and psychosis in Alzheimer's disease. , 1989, The American journal of psychiatry.